Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma (MM) is a hematologic disorder that is incurable and relapses due to its resistance capability towards bortezomib (BTZ). Our study aimed to overcome the BTZ resistance problem of MM by exploring an anti-MM agent. In this study, we reported the significant inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Abdul, Wang, Haiqin, Wang, Yanpeng, Li, Zhenzhen, Yang, Chaoying, Ma, Zekang, Xiao, Xiaojuan, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001131/
https://www.ncbi.nlm.nih.gov/pubmed/36900317
http://dx.doi.org/10.3390/cancers15051526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001131/
https://www.ncbi.nlm.nih.gov/pubmed/36900317
http://dx.doi.org/10.3390/cancers15051526

Ejemplares similares